Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.

NCT02296138 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

7903

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: olodaterol
DRUG: tiotropium
DRUG: tiotropium

Sponsor

Boehringer Ingelheim